Alere Pays $33.2M To Settle False Claims Suit Involving Fast Blood Chemistry Tests
BALTIMORE — Alere Inc. and subsidiary Alere San Diego (Alere) have agreed to pay $33.2 million to settle False Claims Act allegations that they sold federal health programs rapid blood chemistry...To view the full article, register now.
Already a subscriber? Click here to view full article